The White House announced that new data shows prescription drug prices have experienced their largest annual decline in over 60 years, marking the steepest drop since 1963. This was attributed to the Donald Trump administration's "Most Favored Nation" policy, which prompted 17 major pharmaceutical manufacturers to agree to align U.S. drug prices with the lowest prices in comparable developed countries. Since President Donald Trump took office, prescription drug prices have cumulatively decreased by 3.9% and are projected to continue declining monthly through 2026. Furthermore, the Donald Trump administration's TrumpRx platform has saved millions of American patients $700 million, and the "Most Favored Nation" framework is expected to yield hundreds of billions of dollars in long-term savings.